Skip to main content
VCbacked
Log inGet Started

UTR Therapeutics Inc.

New York, United States

Platform therapeutics company advancing novel treatments for Oncology, Neurodegenerative Disorders, and Rare Diseases

$400K raised
May 2022
Pre-Seed
BiotechnologyLife ScienceOncology

Top Investors

Deerfield ManagementNew York City Economic Development Corporation - NYCEDC

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about UTR Therapeutics Inc.

How much funding has UTR Therapeutics Inc. raised?
UTR Therapeutics Inc. has raised $400K in total funding. The most recent round was Pre-Seed. The last funding was announced in May 2022.
Who are UTR Therapeutics Inc.'s investors?
UTR Therapeutics Inc.'s investors include Deerfield Management, New York City Economic Development Corporation - NYCEDC.
Where is UTR Therapeutics Inc. headquartered?
UTR Therapeutics Inc. is headquartered in New York, United States.
What does UTR Therapeutics Inc. do?
Platform therapeutics company advancing novel treatments for Oncology, Neurodegenerative Disorders, and Rare Diseases
What stage is UTR Therapeutics Inc. at?
UTR Therapeutics Inc. is at the Pre-Seed stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"UTR Therapeutics Inc. — Funding & Investors." VCBacked, May 17, 2022, https://www.vcbacked.co/company/utr-therapeutics-inc. Accessed July 2, 2026.
APA
VCBacked. (2022). UTR Therapeutics Inc. — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/utr-therapeutics-inc
Wikipedia (cite web)
{{cite web |title=UTR Therapeutics Inc. — Funding & Investors |url=https://www.vcbacked.co/company/utr-therapeutics-inc |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biotechnology

View all
Renaissance BioScience
Vancouver$599K
Allterum Therapeutics
Houston$1.0M
Rapport Therapeutics
Boston$250.0M
AlpalifeBio
Woburn$9.8M
Epsilogen
London$16.3M
Advanced Microbiome Interventions
Amsterdam$300K